Surgery cost-effective alternative to Remicade for ileocecal Crohn’s maintenance

Laparoscopic ileocecal resection is a cost-effective alternative to Remicade therapy for the treatment of ileocecal Crohn’s disease, according to results of a randomized, controlled trial.
Willem A. Bemelman, MD, PhD, of the department of surgery at Amsterdam UMC in the Netherlands, and colleagues wrote that despite recent medical advances, patients with CD still need lifelong medical therapy.
“Patients failing conventional therapy are traditionally upscaled to antitumor necrosis factor therapy, such as infliximab [Remicade, Janssen],” they wrote. “However, the LIR!C

Source link

Related posts

New PSC risk scores predict mortality, transplant outcomes up to 10 years


For the first time, more women than men are in medical school


Microbial-host interactions in inflammatory bowel disease, functional bowel disease, obesity and obesity-related metabolic disease


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy